Global Ocular Drug Excipient Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • receipt Report ID : 347273
  • calendar_today Published On: May, 2023
  • file_copy Pages: 165
  • list Chemical and Material
Buy @ $3500

Excipients are important part of the drug development process and ensure that the formulation remains stable throughout the development process as well when it is administered. It is basically any other component of the drug outside the medicinal component as it acts as a vehicle or a carrier for the medicinal product. This way stability to the formulation is provided. Wrong selection of excipient can lead to complications like intoxication of the patients. In ocular drugs, they play an important role in maintaining the tonicity, pH, stability, viscosity and sterility of the formulation.

According to our latest study, the global Ocular Drug Excipient market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Ocular Drug Excipient market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Ocular Drug Excipient market size and forecasts, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029

Global Ocular Drug Excipient market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029

Global Ocular Drug Excipient market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kiloton), and average selling prices (US$/Ton), 2018-2029

Global Ocular Drug Excipient market shares of main players, shipments in revenue ($ Million), sales quantity (Kiloton), and ASP (US$/Ton), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Ocular Drug Excipient

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Ocular Drug Excipient market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BASF, Beneo, Evonik, Excipact and Fuji Chemical Industries, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation

Ocular Drug Excipient market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Organic Compounds

Inorganic Compounds

Market segment by Application

Pharmaceutical Companies

Biopharmaceutical Companies

Contract Manufacturing Organizations (CMOs)

Others

Major players covered

BASF

Beneo

Evonik

Excipact

Fuji Chemical Industries

InVitria

Innophos

JRS Pharma

IOI Oleochemical

Millipore Sigma

Mallinckrodt Pharmaceuticals

Pfanstiehl

PerkinElmer

Natoli

DFE Pharma

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Ocular Drug Excipient product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Ocular Drug Excipient, with price, sales, revenue and global market share of Ocular Drug Excipient from 2018 to 2023.

Chapter 3, the Ocular Drug Excipient competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Ocular Drug Excipient breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Ocular Drug Excipient market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.

Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.

Chapter 13, the key raw materials and key suppliers, and industry chain of Ocular Drug Excipient.

Chapter 14 and 15, to describe Ocular Drug Excipient sales channel, distributors, customers, research findings and conclusion.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Ocular Drug Excipient

1.2 Market Estimation Caveats and Base Year

1.3 Market Analysis by Type

1.3.1 Overview: Global Ocular Drug Excipient Consumption Value by Type: 2018 Versus 2022 Versus 2029

1.3.2 Organic Compounds

1.3.3 Inorganic Compounds

1.4 Market Analysis by Application

1.4.1 Overview: Global Ocular Drug Excipient Consumption Value by Application: 2018 Versus 2022 Versus 2029

1.4.2 Pharmaceutical Companies

1.4.3 Biopharmaceutical Companies

1.4.4 Contract Manufacturing Organizations (CMOs)

1.4.5 Others

1.5 Global Ocular Drug Excipient Market Size & Forecast

1.5.1 Global Ocular Drug Excipient Consumption Value (2018 & 2022 & 2029)

1.5.2 Global Ocular Drug Excipient Sales Quantity (2018-2029)

1.5.3 Global Ocular Drug Excipient Average Price (2018-2029)

2 Manufacturers Profiles

2.1 BASF

2.1.1 BASF Details

2.1.2 BASF Major Business

2.1.3 BASF Ocular Drug Excipient Product and Services

2.1.4 BASF Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.1.5 BASF Recent Developments/Updates

2.2 Beneo

2.2.1 Beneo Details

2.2.2 Beneo Major Business

2.2.3 Beneo Ocular Drug Excipient Product and Services

2.2.4 Beneo Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.2.5 Beneo Recent Developments/Updates

2.3 Evonik

2.3.1 Evonik Details

2.3.2 Evonik Major Business

2.3.3 Evonik Ocular Drug Excipient Product and Services

2.3.4 Evonik Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.3.5 Evonik Recent Developments/Updates

2.4 Excipact

2.4.1 Excipact Details

2.4.2 Excipact Major Business

2.4.3 Excipact Ocular Drug Excipient Product and Services

2.4.4 Excipact Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.4.5 Excipact Recent Developments/Updates

2.5 Fuji Chemical Industries

2.5.1 Fuji Chemical Industries Details

2.5.2 Fuji Chemical Industries Major Business

2.5.3 Fuji Chemical Industries Ocular Drug Excipient Product and Services

2.5.4 Fuji Chemical Industries Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.5.5 Fuji Chemical Industries Recent Developments/Updates

2.6 InVitria

2.6.1 InVitria Details

2.6.2 InVitria Major Business

2.6.3 InVitria Ocular Drug Excipient Product and Services

2.6.4 InVitria Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.6.5 InVitria Recent Developments/Updates

2.7 Innophos

2.7.1 Innophos Details

2.7.2 Innophos Major Business

2.7.3 Innophos Ocular Drug Excipient Product and Services

2.7.4 Innophos Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.7.5 Innophos Recent Developments/Updates

2.8 JRS Pharma

2.8.1 JRS Pharma Details

2.8.2 JRS Pharma Major Business

2.8.3 JRS Pharma Ocular Drug Excipient Product and Services

2.8.4 JRS Pharma Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.8.5 JRS Pharma Recent Developments/Updates

2.9 IOI Oleochemical

2.9.1 IOI Oleochemical Details

2.9.2 IOI Oleochemical Major Business

2.9.3 IOI Oleochemical Ocular Drug Excipient Product and Services

2.9.4 IOI Oleochemical Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.9.5 IOI Oleochemical Recent Developments/Updates

2.10 Millipore Sigma

2.10.1 Millipore Sigma Details

2.10.2 Millipore Sigma Major Business

2.10.3 Millipore Sigma Ocular Drug Excipient Product and Services

2.10.4 Millipore Sigma Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.10.5 Millipore Sigma Recent Developments/Updates

2.11 Mallinckrodt Pharmaceuticals

2.11.1 Mallinckrodt Pharmaceuticals Details

2.11.2 Mallinckrodt Pharmaceuticals Major Business

2.11.3 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product and Services

2.11.4 Mallinckrodt Pharmaceuticals Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.11.5 Mallinckrodt Pharmaceuticals Recent Developments/Updates

2.12 Pfanstiehl

2.12.1 Pfanstiehl Details

2.12.2 Pfanstiehl Major Business

2.12.3 Pfanstiehl Ocular Drug Excipient Product and Services

2.12.4 Pfanstiehl Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.12.5 Pfanstiehl Recent Developments/Updates

2.13 PerkinElmer

2.13.1 PerkinElmer Details

2.13.2 PerkinElmer Major Business

2.13.3 PerkinElmer Ocular Drug Excipient Product and Services

2.13.4 PerkinElmer Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.13.5 PerkinElmer Recent Developments/Updates

2.14 Natoli

2.14.1 Natoli Details

2.14.2 Natoli Major Business

2.14.3 Natoli Ocular Drug Excipient Product and Services

2.14.4 Natoli Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.14.5 Natoli Recent Developments/Updates

2.15 DFE Pharma

2.15.1 DFE Pharma Details

2.15.2 DFE Pharma Major Business

2.15.3 DFE Pharma Ocular Drug Excipient Product and Services

2.15.4 DFE Pharma Ocular Drug Excipient Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)

2.15.5 DFE Pharma Recent Developments/Updates

3 Competitive Environment: Ocular Drug Excipient by Manufacturer

3.1 Global Ocular Drug Excipient Sales Quantity by Manufacturer (2018-2023)

3.2 Global Ocular Drug Excipient Revenue by Manufacturer (2018-2023)

3.3 Global Ocular Drug Excipient Average Price by Manufacturer (2018-2023)

3.4 Market Share Analysis (2022)

3.4.1 Producer Shipments of Ocular Drug Excipient by Manufacturer Revenue ($MM) and Market Share (%): 2022

3.4.2 Top 3 Ocular Drug Excipient Manufacturer Market Share in 2022

3.4.2 Top 6 Ocular Drug Excipient Manufacturer Market Share in 2022

3.5 Ocular Drug Excipient Market: Overall Company Footprint Analysis

3.5.1 Ocular Drug Excipient Market: Region Footprint

3.5.2 Ocular Drug Excipient Market: Company Product Type Footprint

3.5.3 Ocular Drug Excipient Market: Company Product Application Footprint

3.6 New Market Entrants and Barriers to Market Entry

3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Ocular Drug Excipient Market Size by Region

4.1.1 Global Ocular Drug Excipient Sales Quantity by Region (2018-2029)

4.1.2 Global Ocular Drug Excipient Consumption Value by Region (2018-2029)

4.1.3 Global Ocular Drug Excipient Average Price by Region (2018-2029)

4.2 North America Ocular Drug Excipient Consumption Value (2018-2029)

4.3 Europe Ocular Drug Excipient Consumption Value (2018-2029)

4.4 Asia-Pacific Ocular Drug Excipient Consumption Value (2018-2029)

4.5 South America Ocular Drug Excipient Consumption Value (2018-2029)

4.6 Middle East and Africa Ocular Drug Excipient Consumption Value (2018-2029)

5 Market Segment by Type

5.1 Global Ocular Drug Excipient Sales Quantity by Type (2018-2029)

5.2 Global Ocular Drug Excipient Consumption Value by Type (2018-2029)

5.3 Global Ocular Drug Excipient Average Price by Type (2018-2029)

6 Market Segment by Application

6.1 Global Ocular Drug Excipient Sales Quantity by Application (2018-2029)

6.2 Global Ocular Drug Excipient Consumption Value by Application (2018-2029)

6.3 Global Ocular Drug Excipient Average Price by Application (2018-2029)

7 North America

7.1 North America Ocular Drug Excipient Sales Quantity by Type (2018-2029)

7.2 North America Ocular Drug Excipient Sales Quantity by Application (2018-2029)

7.3 North America Ocular Drug Excipient Market Size by Country

7.3.1 North America Ocular Drug Excipient Sales Quantity by Country (2018-2029)

7.3.2 North America Ocular Drug Excipient Consumption Value by Country (2018-2029)

7.3.3 United States Market Size and Forecast (2018-2029)

7.3.4 Canada Market Size and Forecast (2018-2029)

7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

8.1 Europe Ocular Drug Excipient Sales Quantity by Type (2018-2029)

8.2 Europe Ocular Drug Excipient Sales Quantity by Application (2018-2029)

8.3 Europe Ocular Drug Excipient Market Size by Country

8.3.1 Europe Ocular Drug Excipient Sales Quantity by Country (2018-2029)

8.3.2 Europe Ocular Drug Excipient Consumption Value by Country (2018-2029)

8.3.3 Germany Market Size and Forecast (2018-2029)

8.3.4 France Market Size and Forecast (2018-2029)

8.3.5 United Kingdom Market Size and Forecast (2018-2029)

8.3.6 Russia Market Size and Forecast (2018-2029)

8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

9.1 Asia-Pacific Ocular Drug Excipient Sales Quantity by Type (2018-2029)

9.2 Asia-Pacific Ocular Drug Excipient Sales Quantity by Application (2018-2029)

9.3 Asia-Pacific Ocular Drug Excipient Market Size by Region

9.3.1 Asia-Pacific Ocular Drug Excipient Sales Quantity by Region (2018-2029)

9.3.2 Asia-Pacific Ocular Drug Excipient Consumption Value by Region (2018-2029)

9.3.3 China Market Size and Forecast (2018-2029)

9.3.4 Japan Market Size and Forecast (2018-2029)

9.3.5 Korea Market Size and Forecast (2018-2029)

9.3.6 India Market Size and Forecast (2018-2029)

9.3.7 Southeast Asia Market Size and Forecast (2018-2029)

9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

10.1 South America Ocular Drug Excipient Sales Quantity by Type (2018-2029)

10.2 South America Ocular Drug Excipient Sales Quantity by Application (2018-2029)

10.3 South America Ocular Drug Excipient Market Size by Country

10.3.1 South America Ocular Drug Excipient Sales Quantity by Country (2018-2029)

10.3.2 South America Ocular Drug Excipient Consumption Value by Country (2018-2029)

10.3.3 Brazil Market Size and Forecast (2018-2029)

10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

11.1 Middle East & Africa Ocular Drug Excipient Sales Quantity by Type (2018-2029)

11.2 Middle East & Africa Ocular Drug Excipient Sales Quantity by Application (2018-2029)

11.3 Middle East & Africa Ocular Drug Excipient Market Size by Country

11.3.1 Middle East & Africa Ocular Drug Excipient Sales Quantity by Country (2018-2029)

11.3.2 Middle East & Africa Ocular Drug Excipient Consumption Value by Country (2018-2029)

11.3.3 Turkey Market Size and Forecast (2018-2029)

11.3.4 Egypt Market Size and Forecast (2018-2029)

11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)

11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

12.1 Ocular Drug Excipient Market Drivers

12.2 Ocular Drug Excipient Market Restraints

12.3 Ocular Drug Excipient Trends Analysis

12.4 Porters Five Forces Analysis

12.4.1 Threat of New Entrants

12.4.2 Bargaining Power of Suppliers

12.4.3 Bargaining Power of Buyers

12.4.4 Threat of Substitutes

12.4.5 Competitive Rivalry

12.5 Influence of COVID-19 and Russia-Ukraine War

12.5.1 Influence of COVID-19

12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

13.1 Raw Material of Ocular Drug Excipient and Key Manufacturers

13.2 Manufacturing Costs Percentage of Ocular Drug Excipient

13.3 Ocular Drug Excipient Production Process

13.4 Ocular Drug Excipient Industrial Chain

14 Shipments by Distribution Channel

14.1 Sales Channel

14.1.1 Direct to End-User

14.1.2 Distributors

14.2 Ocular Drug Excipient Typical Distributors

14.3 Ocular Drug Excipient Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology

16.2 Research Process and Data Source

16.3 Disclaimer

List of Tables

Table 1. Global Ocular Drug Excipient Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Table 2. Global Ocular Drug Excipient Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Table 3. BASF Basic Information, Manufacturing Base and Competitors

Table 4. BASF Major Business

Table 5. BASF Ocular Drug Excipient Product and Services

Table 6. BASF Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 7. BASF Recent Developments/Updates

Table 8. Beneo Basic Information, Manufacturing Base and Competitors

Table 9. Beneo Major Business

Table 10. Beneo Ocular Drug Excipient Product and Services

Table 11. Beneo Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 12. Beneo Recent Developments/Updates

Table 13. Evonik Basic Information, Manufacturing Base and Competitors

Table 14. Evonik Major Business

Table 15. Evonik Ocular Drug Excipient Product and Services

Table 16. Evonik Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 17. Evonik Recent Developments/Updates

Table 18. Excipact Basic Information, Manufacturing Base and Competitors

Table 19. Excipact Major Business

Table 20. Excipact Ocular Drug Excipient Product and Services

Table 21. Excipact Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 22. Excipact Recent Developments/Updates

Table 23. Fuji Chemical Industries Basic Information, Manufacturing Base and Competitors

Table 24. Fuji Chemical Industries Major Business

Table 25. Fuji Chemical Industries Ocular Drug Excipient Product and Services

Table 26. Fuji Chemical Industries Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 27. Fuji Chemical Industries Recent Developments/Updates

Table 28. InVitria Basic Information, Manufacturing Base and Competitors

Table 29. InVitria Major Business

Table 30. InVitria Ocular Drug Excipient Product and Services

Table 31. InVitria Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 32. InVitria Recent Developments/Updates

Table 33. Innophos Basic Information, Manufacturing Base and Competitors

Table 34. Innophos Major Business

Table 35. Innophos Ocular Drug Excipient Product and Services

Table 36. Innophos Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 37. Innophos Recent Developments/Updates

Table 38. JRS Pharma Basic Information, Manufacturing Base and Competitors

Table 39. JRS Pharma Major Business

Table 40. JRS Pharma Ocular Drug Excipient Product and Services

Table 41. JRS Pharma Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 42. JRS Pharma Recent Developments/Updates

Table 43. IOI Oleochemical Basic Information, Manufacturing Base and Competitors

Table 44. IOI Oleochemical Major Business

Table 45. IOI Oleochemical Ocular Drug Excipient Product and Services

Table 46. IOI Oleochemical Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 47. IOI Oleochemical Recent Developments/Updates

Table 48. Millipore Sigma Basic Information, Manufacturing Base and Competitors

Table 49. Millipore Sigma Major Business

Table 50. Millipore Sigma Ocular Drug Excipient Product and Services

Table 51. Millipore Sigma Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 52. Millipore Sigma Recent Developments/Updates

Table 53. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors

Table 54. Mallinckrodt Pharmaceuticals Major Business

Table 55. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Product and Services

Table 56. Mallinckrodt Pharmaceuticals Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 57. Mallinckrodt Pharmaceuticals Recent Developments/Updates

Table 58. Pfanstiehl Basic Information, Manufacturing Base and Competitors

Table 59. Pfanstiehl Major Business

Table 60. Pfanstiehl Ocular Drug Excipient Product and Services

Table 61. Pfanstiehl Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 62. Pfanstiehl Recent Developments/Updates

Table 63. PerkinElmer Basic Information, Manufacturing Base and Competitors

Table 64. PerkinElmer Major Business

Table 65. PerkinElmer Ocular Drug Excipient Product and Services

Table 66. PerkinElmer Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 67. PerkinElmer Recent Developments/Updates

Table 68. Natoli Basic Information, Manufacturing Base and Competitors

Table 69. Natoli Major Business

Table 70. Natoli Ocular Drug Excipient Product and Services

Table 71. Natoli Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 72. Natoli Recent Developments/Updates

Table 73. DFE Pharma Basic Information, Manufacturing Base and Competitors

Table 74. DFE Pharma Major Business

Table 75. DFE Pharma Ocular Drug Excipient Product and Services

Table 76. DFE Pharma Ocular Drug Excipient Sales Quantity (Kiloton), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2018-2023)

Table 77. DFE Pharma Recent Developments/Updates

Table 78. Global Ocular Drug Excipient Sales Quantity by Manufacturer (2018-2023) & (Kiloton)

Table 79. Global Ocular Drug Excipient Revenue by Manufacturer (2018-2023) & (USD Million)

Table 80. Global Ocular Drug Excipient Average Price by Manufacturer (2018-2023) & (US$/Ton)

Table 81. Market Position of Manufacturers in Ocular Drug Excipient, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022

Table 82. Head Office and Ocular Drug Excipient Production Site of Key Manufacturer

Table 83. Ocular Drug Excipient Market: Company Product Type Footprint

Table 84. Ocular Drug Excipient Market: Company Product Application Footprint

Table 85. Ocular Drug Excipient New Market Entrants and Barriers to Market Entry

Table 86. Ocular Drug Excipient Mergers, Acquisition, Agreements, and Collaborations

Table 87. Global Ocular Drug Excipient Sales Quantity by Region (2018-2023) & (Kiloton)

Table 88. Global Ocular Drug Excipient Sales Quantity by Region (2024-2029) & (Kiloton)

Table 89. Global Ocular Drug Excipient Consumption Value by Region (2018-2023) & (USD Million)

Table 90. Global Ocular Drug Excipient Consumption Value by Region (2024-2029) & (USD Million)

Table 91. Global Ocular Drug Excipient Average Price by Region (2018-2023) & (US$/Ton)

Table 92. Global Ocular Drug Excipient Average Price by Region (2024-2029) & (US$/Ton)

Table 93. Global Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 94. Global Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 95. Global Ocular Drug Excipient Consumption Value by Type (2018-2023) & (USD Million)

Table 96. Global Ocular Drug Excipient Consumption Value by Type (2024-2029) & (USD Million)

Table 97. Global Ocular Drug Excipient Average Price by Type (2018-2023) & (US$/Ton)

Table 98. Global Ocular Drug Excipient Average Price by Type (2024-2029) & (US$/Ton)

Table 99. Global Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 100. Global Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 101. Global Ocular Drug Excipient Consumption Value by Application (2018-2023) & (USD Million)

Table 102. Global Ocular Drug Excipient Consumption Value by Application (2024-2029) & (USD Million)

Table 103. Global Ocular Drug Excipient Average Price by Application (2018-2023) & (US$/Ton)

Table 104. Global Ocular Drug Excipient Average Price by Application (2024-2029) & (US$/Ton)

Table 105. North America Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 106. North America Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 107. North America Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 108. North America Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 109. North America Ocular Drug Excipient Sales Quantity by Country (2018-2023) & (Kiloton)

Table 110. North America Ocular Drug Excipient Sales Quantity by Country (2024-2029) & (Kiloton)

Table 111. North America Ocular Drug Excipient Consumption Value by Country (2018-2023) & (USD Million)

Table 112. North America Ocular Drug Excipient Consumption Value by Country (2024-2029) & (USD Million)

Table 113. Europe Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 114. Europe Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 115. Europe Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 116. Europe Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 117. Europe Ocular Drug Excipient Sales Quantity by Country (2018-2023) & (Kiloton)

Table 118. Europe Ocular Drug Excipient Sales Quantity by Country (2024-2029) & (Kiloton)

Table 119. Europe Ocular Drug Excipient Consumption Value by Country (2018-2023) & (USD Million)

Table 120. Europe Ocular Drug Excipient Consumption Value by Country (2024-2029) & (USD Million)

Table 121. Asia-Pacific Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 122. Asia-Pacific Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 123. Asia-Pacific Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 124. Asia-Pacific Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 125. Asia-Pacific Ocular Drug Excipient Sales Quantity by Region (2018-2023) & (Kiloton)

Table 126. Asia-Pacific Ocular Drug Excipient Sales Quantity by Region (2024-2029) & (Kiloton)

Table 127. Asia-Pacific Ocular Drug Excipient Consumption Value by Region (2018-2023) & (USD Million)

Table 128. Asia-Pacific Ocular Drug Excipient Consumption Value by Region (2024-2029) & (USD Million)

Table 129. South America Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 130. South America Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 131. South America Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 132. South America Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 133. South America Ocular Drug Excipient Sales Quantity by Country (2018-2023) & (Kiloton)

Table 134. South America Ocular Drug Excipient Sales Quantity by Country (2024-2029) & (Kiloton)

Table 135. South America Ocular Drug Excipient Consumption Value by Country (2018-2023) & (USD Million)

Table 136. South America Ocular Drug Excipient Consumption Value by Country (2024-2029) & (USD Million)

Table 137. Middle East & Africa Ocular Drug Excipient Sales Quantity by Type (2018-2023) & (Kiloton)

Table 138. Middle East & Africa Ocular Drug Excipient Sales Quantity by Type (2024-2029) & (Kiloton)

Table 139. Middle East & Africa Ocular Drug Excipient Sales Quantity by Application (2018-2023) & (Kiloton)

Table 140. Middle East & Africa Ocular Drug Excipient Sales Quantity by Application (2024-2029) & (Kiloton)

Table 141. Middle East & Africa Ocular Drug Excipient Sales Quantity by Region (2018-2023) & (Kiloton)

Table 142. Middle East & Africa Ocular Drug Excipient Sales Quantity by Region (2024-2029) & (Kiloton)

Table 143. Middle East & Africa Ocular Drug Excipient Consumption Value by Region (2018-2023) & (USD Million)

Table 144. Middle East & Africa Ocular Drug Excipient Consumption Value by Region (2024-2029) & (USD Million)

Table 145. Ocular Drug Excipient Raw Material

Table 146. Key Manufacturers of Ocular Drug Excipient Raw Materials

Table 147. Ocular Drug Excipient Typical Distributors

Table 148. Ocular Drug Excipient Typical Customers

List of Figures

Figure 1. Ocular Drug Excipient Picture

Figure 2. Global Ocular Drug Excipient Consumption Value by Type, (USD Million), 2018 & 2022 & 2029

Figure 3. Global Ocular Drug Excipient Consumption Value Market Share by Type in 2022

Figure 4. Organic Compounds Examples

Figure 5. Inorganic Compounds Examples

Figure 6. Global Ocular Drug Excipient Consumption Value by Application, (USD Million), 2018 & 2022 & 2029

Figure 7. Global Ocular Drug Excipient Consumption Value Market Share by Application in 2022

Figure 8. Pharmaceutical Companies Examples

Figure 9. Biopharmaceutical Companies Examples

Figure 10. Contract Manufacturing Organizations (CMOs) Examples

Figure 11. Others Examples

Figure 12. Global Ocular Drug Excipient Consumption Value, (USD Million): 2018 & 2022 & 2029

Figure 13. Global Ocular Drug Excipient Consumption Value and Forecast (2018-2029) & (USD Million)

Figure 14. Global Ocular Drug Excipient Sales Quantity (2018-2029) & (Kiloton)

Figure 15. Global Ocular Drug Excipient Average Price (2018-2029) & (US$/Ton)

Figure 16. Global Ocular Drug Excipient Sales Quantity Market Share by Manufacturer in 2022

Figure 17. Global Ocular Drug Excipient Consumption Value Market Share by Manufacturer in 2022

Figure 18. Producer Shipments of Ocular Drug Excipient by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021

Figure 19. Top 3 Ocular Drug Excipient Manufacturer (Consumption Value) Market Share in 2022

Figure 20. Top 6 Ocular Drug Excipient Manufacturer (Consumption Value) Market Share in 2022

Figure 21. Global Ocular Drug Excipient Sales Quantity Market Share by Region (2018-2029)

Figure 22. Global Ocular Drug Excipient Consumption Value Market Share by Region (2018-2029)

Figure 23. North America Ocular Drug Excipient Consumption Value (2018-2029) & (USD Million)

Figure 24. Europe Ocular Drug Excipient Consumption Value (2018-2029) & (USD Million)

Figure 25. Asia-Pacific Ocular Drug Excipient Consumption Value (2018-2029) & (USD Million)

Figure 26. South America Ocular Drug Excipient Consumption Value (2018-2029) & (USD Million)

Figure 27. Middle East & Africa Ocular Drug Excipient Consumption Value (2018-2029) & (USD Million)

Figure 28. Global Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 29. Global Ocular Drug Excipient Consumption Value Market Share by Type (2018-2029)

Figure 30. Global Ocular Drug Excipient Average Price by Type (2018-2029) & (US$/Ton)

Figure 31. Global Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 32. Global Ocular Drug Excipient Consumption Value Market Share by Application (2018-2029)

Figure 33. Global Ocular Drug Excipient Average Price by Application (2018-2029) & (US$/Ton)

Figure 34. North America Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 35. North America Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 36. North America Ocular Drug Excipient Sales Quantity Market Share by Country (2018-2029)

Figure 37. North America Ocular Drug Excipient Consumption Value Market Share by Country (2018-2029)

Figure 38. United States Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 39. Canada Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 40. Mexico Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 41. Europe Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 42. Europe Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 43. Europe Ocular Drug Excipient Sales Quantity Market Share by Country (2018-2029)

Figure 44. Europe Ocular Drug Excipient Consumption Value Market Share by Country (2018-2029)

Figure 45. Germany Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 46. France Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 47. United Kingdom Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 48. Russia Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 49. Italy Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 50. Asia-Pacific Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 51. Asia-Pacific Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 52. Asia-Pacific Ocular Drug Excipient Sales Quantity Market Share by Region (2018-2029)

Figure 53. Asia-Pacific Ocular Drug Excipient Consumption Value Market Share by Region (2018-2029)

Figure 54. China Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 55. Japan Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 56. Korea Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 57. India Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 58. Southeast Asia Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 59. Australia Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 60. South America Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 61. South America Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 62. South America Ocular Drug Excipient Sales Quantity Market Share by Country (2018-2029)

Figure 63. South America Ocular Drug Excipient Consumption Value Market Share by Country (2018-2029)

Figure 64. Brazil Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 65. Argentina Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 66. Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share by Type (2018-2029)

Figure 67. Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share by Application (2018-2029)

Figure 68. Middle East & Africa Ocular Drug Excipient Sales Quantity Market Share by Region (2018-2029)

Figure 69. Middle East & Africa Ocular Drug Excipient Consumption Value Market Share by Region (2018-2029)

Figure 70. Turkey Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 71. Egypt Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 72. Saudi Arabia Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 73. South Africa Ocular Drug Excipient Consumption Value and Growth Rate (2018-2029) & (USD Million)

Figure 74. Ocular Drug Excipient Market Drivers

Figure 75. Ocular Drug Excipient Market Restraints

Figure 76. Ocular Drug Excipient Market Trends

Figure 77. Porters Five Forces Analysis

Figure 78. Manufacturing Cost Structure Analysis of Ocular Drug Excipient in 2022

Figure 79. Manufacturing Process Analysis of Ocular Drug Excipient

Figure 80. Ocular Drug Excipient Industrial Chain

Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors

Figure 82. Direct Channel Pros & Cons

Figure 83. Indirect Channel Pros & Cons

Figure 84. Methodology

Figure 85. Research Process and Data Source